Yanks, Tigers prevail in 3-team Granderson deal

Leave a comment

Thumbnail image for granderson tigers.jpgThe incredible thing is that the Diamondbacks were supposed to be the driving force behind the whole thing.
Maybe GM Josh Byrnes was simply so eager to get the deal done that he lost his way, but it looks like the Diamondbacks are really losing out in the three-team deal sending Curtis Granderson to New York, Max Scherzer to Detroit and Edwin Jackson to Arizona.
The full deal (ages as of Opening Day, 2010):
New York gets
Granderson (29) – from Detroit
Detroit gets
Scherzer (25) – from Arizona
Austin Jackson (23) – from New York
Daniel Schlereth (23) – from Arizona
Phil Coke (27) – from New York
Arizona gets
Edwin Jackson (26) – from Detroit
Ian Kennedy (25) – from New York
One can make a case for Scherzer as the most valuable player in the deal. The 11th overall pick in the 2006 draft went 9-11 with a 4.12 ERA in his first full major league season. Now that sounds pretty unremarkable, but along the way, he fanned 174 in 170 1/3 innings. Scherzer’s 92-96 mph fastball and slider are both strikeout pitches. His changeup lags behind, but he could turn into a legitimate top-30 starter.
The concern with Scherzer is durability. He’s had some shoulder problems, and the Diamondbacks must not be sold on him developing into a reliable 200-inning-per-year guy. That’s the only reason it makes any sense to trade him for Edwin Jackson.
Not that Jackson is chopped liver. He was one of the AL’s best pitchers for five months last season before tumbling in September and finishing 13-9 with a 3.62 ERA. But Jackson is just two years away from free agency and is going to make at least $5 million next season. If he turns in another strong campaign, he’ll be due $8 million-$10 million in 2011. Scherzer is five years away from free agency. If Jackson is the slightly better bet on the mound for the next two years, the difference in salaries more than makes up for it.
The secondary pieces in the deal don’t even it up for the Diamondbacks. Schlereth was their top pick in the 2008 draft. The left-hander is purely a reliever and he has command issues, but he’s also a strikeout machine with his 92-95 mph fastball and hard curve. He could battle it out with Ryan Perry to be the Tigers’ long-term closer (pending a still possible Joel Zumaya comeback).
Kennedy was viewed as a legitimate No. 3 starter two years ago, but he faltered badly for the Yankees in 2008 and he missed most of last season following surgery for an aneurysm under his armpit. His fastball is below average, but he does have a four-pitch arsenal that could make him a decent enough National League pitcher. Ideally, he’s a cheap No. 4 now. He is worth gambling on, yet I’d still rather have Schlereth going forward.
So, the Diamondbacks lose. And I think it’s a big enough loss to make the deal a win for the other two teams.
Granderson’s defense has slipped a bit and it looks like he’ll always be a liability against lefties, but he still brings quite a bit to the table and he should put up some big numbers in center field for the Yankees. His contract is also manageable, as he’s due $5.5 million next year, $8.25 million in 2011, $10 million in 2012 and then $13 million or a $2 million buyout in 2013.
Perhaps the Yankees should have just signed Mike Cameron instead, but the price for Granderson was right. Austin Jackson was the only piece they gave up likely to play a big role going forward.
Austin Jackson becomes the Tigers’ center fielder of the future, if not the present. He got off to a big start in Triple-A last season, but he fell to .300/.354/.405 by season’s end, suggesting that he could use one more year at the level. The Tigers may give him a job now, though, since they need to get cheaper and justify the trade. Jackson projects as an above average regular, but not a star. He has enough range to stay in center for a few years, but he’ll likely need to move to a corner someday. Offensively, he should hit for fine averages and deliver 20 homers per year in his prime.
Scherzer should open the year as the Tigers’ third starter, and Schlereth will have every opportunity to compete for a bullpen spot. Coke, a homer-prone lefty with a solid fastball-slider combo, could be tried as a starter. The Tigers might now have the financial flexibility to up their bid for a veteran closer and take a look at some potential fourth starters and outfielders. They could definitely use a top-of-the-order guy with both Granderson and Placido Polanco gone.
With Granderson in New York, it seems awfully unlikely that the Yankees will re-sign both Johnny Damon and Hideki Matsui. Everyone seems to think Damon is the better bet to stay. Melky Cabrera should be available in trade talks, but Brett Gardner is also a candidate to go. Since he, like Granderson, is a left-handed hitter, he’d probably be less useful as a reserve than Cabrera going forward.

The Padres non-tendered RHP Tyson Ross

SAN DIEGO, CALIFORNIA - APRIL 04:  Tyson Ross #38 of the San Diego Padres walks off the field as he's taken out of the game in the sixth inning of a baseball game against the Los Angeles Dodgers on opening day at PETCO Park on April 4, 2016 in San Diego, California.  (Photo by Denis Poroy/Getty Images)
Getty Images
Leave a comment

Per a report by MLB.com’s AJ Cassavell, the Padres non-tendered right-handed starter Tyson Ross on Friday, cutting loose their top ace after three seasons with the club.

Ross, 29, was sidelined for the bulk of the season with inflammation in his right shoulder and underwent thoracic outlet surgery in October. His injuries limited him to only 5 1/3 innings in 2016, during which he gave up seven runs and struck out five in a 15-0 blowout against the Dodgers.

Prior to his lengthy stint on the disabled list, the right-hander earned 9.5 fWAR and pitched to a 3.07 ERA and 9.2 K/9 rate in three full seasons with the Padres. He avoided arbitration with a one-year, $9.625 million deal prior to the 2016 season after leading the league with 33 starts and delivering a 3.26 ERA and career-best 4.4 WARP over 196 innings in 2015.

The Padres appear open to bringing Ross back to San Diego, reported Cassavell, albeit not at such a steep cost. Cassavell quoted Padres’ GM A.J. Preller, who was reportedly in trade talks involving Ross but unable to strike a deal, likely due to the right-hander’s recent health issues. Preller denied that those same health issues factored into the club’s decision to non-tender their ace.

With the move, Ross became one of 35 major leaguers to enter free agency on Friday.

Angels’ Pujols has foot surgery, could be sidelined 4 months

pujols
Getty Images
2 Comments

ANAHEIM, Calif. — Los Angeles Angels slugger Albert Pujols had surgery on his right foot Friday, possibly sidelining him past opening day.

Angels general manager Billy Eppler said Pujols had the procedure Friday in North Carolina to release his plantar fascia, the ligament connecting the heel to the toes. The three-time NL MVP was bothered by plantar fasciitis repeatedly during the season, but played through the pain in arguably the strongest year of his half-decade with the Angels.

Eppler said the surgery typically prevents players from participating in baseball activities for three months, along with another month before they’re ready to resume playing in games. Opening day for Los Angeles is April 3, and the Angels hope Pujols can be ready.

“He’s at that point in his career where he’s keenly aware of what’s happening with his body,” Eppler said in a phone interview. “I don’t put the timetable on Albert like you would with your younger players. We’ll just see in Albert’s case, as he progresses, what his timetable is.”

Pujols, who turns 37 next month, batted .268 last year with 31 homers and 119 RBIs, the fourth-most in the majors – although his .780 OPS was among the worst of his career. He largely served as a designated hitter instead of playing first base due to problems with his hamstrings and feet.

Pujols heads into 2017 with 591 career homers, ranking him ninth in major league history. He is 18 homers behind Sammy Sosa for eighth place.

After playing in pain until the final week of the Angels’ disappointing season, Pujols began shock wave therapy on his foot early in the offseason, believing he wouldn’t need surgery.

But Pujols’ foot became more painful in recent weeks despite the therapy, and he huddled with the Angels’ top brass to decide on surgery after his most recent trip to see Dr. Robert Anderson in North Carolina. Continuing with conservative care would have required 10 more weeks, forcing Pujols to miss the first half of the 2017 season if he still required surgery.

“He just felt that the pain had gotten to a point where he was comfortable” having surgery, Eppler said. “If we did delay it, you’re just looking at 2 1/2 more months into the season.”

Pujols had a different type of surgery on his right foot last winter, but recovered in time for opening day. He also had plantar fasciitis in his left foot during the 2013 season, eventually forcing him out for the year when his fascia snapped.

Pujols has five years and $140 million remaining on the 10-year, $240 million free-agent contract that pried him out of St. Louis, where he won two World Series and became a nine-time NL All-Star.

The Angels haven’t won a playoff game since Pujols’ arrival and Mike Trout‘s concurrent emergence as one of baseball’s best players. They went 74-88 last season, the injury-plagued club’s worst record since 1999.